Oryza Pharmaceuticals Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Series C

  • Investors
  • 5

Oryza Pharmaceuticals General Information

Description

Developer of innovative drugs designed to provide better treatment for patients. The company offers research and development of innovative drugs for diabetes, digestive system diseases, cardiovascular and cerebrovascular diseases, malignant tumors, and the pharmaceutical preparations process, thereby providing advanced treatment solutions for medical industrial users.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 853, Building B, Wanhe Technology Building, No. 7 Huitong Road, Fenghuang Community
  • Fenghuang Street, Guangming District
  • Shenzhen, Guangdong
  • China
+86 0755
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Room 853, Building B, Wanhe Technology Building, No. 7 Huitong Road, Fenghuang Community
  • Fenghuang Street, Guangming District
  • Shenzhen, Guangdong
  • China
+86 0755

Oryza Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oryza Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 29-Dec-2025 Completed Generating Revenue
5. Secondary Transaction - Private 30-Dec-2025 Completed Generating Revenue
4. Later Stage VC 27-Aug-2024 Completed Generating Revenue
3. Later Stage VC (Series B1) 21-Nov-2023 Completed Generating Revenue
2. Later Stage VC 19-May-2021 $3.09M $3.09M Completed Generating Revenue
1. Corporate 13-Jun-2018 Completed Generating Revenue
To view Oryza Pharmaceuticals’s complete valuation and funding history, request access »

Oryza Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oryza Pharmaceuticals Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Venture Capital Venture Capital Minority
Feixi County Industrial Park Investment Holding (Group) Venture Capital Minority
ASB Ventures Venture Capital Minority
Cowin Capital Venture Capital Minority
Goldport Capital Venture Capital Minority
To view Oryza Pharmaceuticals’s complete investors history, request access »

Oryza Pharmaceuticals FAQs

  • When was Oryza Pharmaceuticals founded?

    Oryza Pharmaceuticals was founded in 2016.

  • Where is Oryza Pharmaceuticals headquartered?

    Oryza Pharmaceuticals is headquartered in Shenzhen, China.

  • What is the size of Oryza Pharmaceuticals?

    Oryza Pharmaceuticals has 14 total employees.

  • What industry is Oryza Pharmaceuticals in?

    Oryza Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is Oryza Pharmaceuticals a private or public company?

    Oryza Pharmaceuticals is a Private company.

  • What is Oryza Pharmaceuticals’s current revenue?

    The current revenue for Oryza Pharmaceuticals is .

  • How much funding has Oryza Pharmaceuticals raised over time?

    Oryza Pharmaceuticals has raised $4.47M.

  • Who are Oryza Pharmaceuticals’s investors?

    China Venture Capital, Feixi County Industrial Park Investment Holding (Group), ASB Ventures, Cowin Capital, and Goldport Capital have invested in Oryza Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process